The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT06536517
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Fibroid Uterus
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Methadone — DRUGIntra-operative single dose IV Methadone (0.25 mg/kg of ideal body weight)
Study Details
Currently, there is a nationwide epidemic of opioid abuse and overdose deaths. One source of excess opioids is overprescribing in the postoperative period. This study aims to find the optimal pain medication plan during and after laparoscopic hysterectomy to eliminate long-term opioid use. Given the increasing opioid abuse and over-prescription post-operatively, an effort should be made to determine whether one time dosing of Methadone, a longer opioid analgesics, intra-operatively is an adequate potential in treating postoperative pain after hysterectomy surgeries. The investigators hypothesize that this could minimize the need for additional post-operative and outpatient opioid prescriptions and decrease the adverse effects that are associated with the consumption, including new opioid abuse. Intervention group will receive methadone intraoperatively while the other group would receive short-acting opioids (standard).
Key Dates
- Start date
- Mar 7, 2025
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: MethadoneIntra-operative single dose IV Methadone (0.25 mg/kg of ideal body weight)
- Other: Short-Acting OpioidStandard intra-operative IV shorter acting opioids
Primary Outcome Measure
Total post-operative opioid requirements in oral morphine milligram equivalents (MME) [ Time Frame: 1 week ]
Central Contacts
- Mostafa Borahay, MD, MBA, PhD410-550-0337
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | Mostafa Borahay |
| The Johns Hopkins Hospital | Baltimore | Maryland | 21287 | Mostafa Borahay |
Find similar trials in Baltimore, MD
Related Studies
- Effects of Simvastatin on Uterine Leiomyoma SizePHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- QL Block in Laparoscopic MyomectomyPHASE4 · Recruiting · Joseph Findley MD · Beachwood, Ohio
- Prescription of Letrozole for Uterine MyomaPHASE4 · Recruiting · University of California, San Francisco · Los Angeles, California